Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 16Observational 4

Sponsor

Cancer Type

Tumor-Agnostic 3Genitourinary 1

Conditions

Neoplasms 4Pancreatic Neoplasms 2Sleep Initiation and Maintenance Disorders 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Lymphoma 1Leukemia 1Kidney Failure, Chronic 1Idiopathic Pulmonary Fibrosis 1Glioblastoma 1Fatigue 1Depression 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Neoplasms × Palliative Care × Clear all
NCT05061342 2026-01-27

TQ-BIRD

The University of Hong Kong-Shenzhen Hospital

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms

NCT06909968 2025-12-03

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Completed
178 enrolled
Genitourinary

Kidney Failure, Chronic, Neoplasms, Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis

NCT05871996 2025-06-27

POST

Our Lady's Hospice and Care Services

Recruiting
1,532 enrolled
Tumor-Agnostic

Neoplasms

NCT03724097 2021-09-14

Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy

OmicsWay Corp.

Unknown
200 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡